Tag

CME Archives | Carevive - cancer care management & patient engagement tools

CME

Clinically Integrating Patient-Reported Outcomes into Triple-Negative Breast Cancer (TNBC) Care to Improve Symptom Management

Release Date: 3/4/2020 Expiration Date: 3/3/2021 Estimated Time to Complete the Activity: 45 minutes Physicians – Maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses – 0.7 contact hours (0.4 pharmacotherapy) The goals of this initiative are to (1) close existing cancer clinician competency gaps regarding newly approved and emerging therapies for Triple-Negative Breast Cancer TNBC and the management…
Carevive
March 4, 2020
CME

Clinically Integrating Patient-Reported Outcomes into Acute Myeloid Leukemia Care Management

Release Date: 11/8/2019 Expiration Date: 11/9/2020 Physicians – Maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses – 1.2 contact hours (0.4 pharmacotherapy) The goal of this project is to identify the variety of symptoms relevant to patients receiving treatment for AML and test the electronic Patient Reported Outcomes (ePRO) tool in the clinical setting. A certified educational training…
Carevive
November 27, 2019
CME

Applying the Shared Decision-Making Model to Inform Treatment Decision Making in Multiple Myeloma (MM)

Release Date: 9/23/2019 Expiration Date: 9/22/2020 Physicians – Maximum of 1.5 AMA PRA Category 1 Credits™ Registered Nurses – 1.4 contact hours (0.4 pharmacotherapy) The goal of this project is to evaluate the effectiveness of a shared decision-making (SDM) model in advancing care outcomes as well as clinician and patient engagement in managing multiple myeloma (MM). We will evaluate the…
Carevive
September 23, 2019
CME

Multiple Myeloma in 2019: Maintenance Therapy & Treatment Side Effect Management

Release Date: 6/7/2019 Expiration Date: 6/6/2020 Physicians – Maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses – 0.6 contact hours (0.3 pharmacotherapy) Target Audience The target audience for this activity is U.S.-based hematologists/oncologists, hematology/oncology NPs/PAs, and registered nurses. Faculty Rafael Fonseca, MD, FACP Mayo Clinic – Arizona Beth Faiman, PhD, APRN-BC, AOCN Cleveland Clinic Educational Objectives After completing this activity, the participant should be…
Carevive
June 18, 2019
CME

Multiple Myeloma in 2019: Updates and Clinical Trial Data

Release Date: 6/7/2019 Expiration Date: 6/6/2020 Physicians – Maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses – 0.6 contact hours (0.3 pharmacotherapy) Target Audience The target audience for this activity is U.S.-based hematologists/oncologists, hematology/oncology NPs/PAs, and registered nurses. Faculty Rafael Fonseca, MD, FACP Mayo Clinic – Arizona Educational Objectives After completing this activity, the participant should be better able to: Consider clinical trial data…
Carevive
June 18, 2019
CME

Multiple Myeloma in 2019: The Geriatric Assessment Tool and Clinical Evidence

Release Date: 6/7/2019 Expiration Date: 6/6/2020 Physicians – Maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses – 0.5 contact hours Target Audience The target audience for this activity is U.S.-based hematologists/oncologists, hematology/oncology NPs/PAs, and registered nurses. Faculty Tanya Wildes, MD, MSCI Washington University School of Medicine Educational Objectives After completing this activity, the participant should be better able to: Consider real-world evidence when managing…
Carevive
June 7, 2019
CME

Clinically Integrating Patient-Reported Outcomes into Metastatic Colorectal Care Management

Release date: May 22, 2019 
Expiration date: May 21, 2020 Physicians – Maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses – 0.5 contact hours (0.2 pharmacotherapy) Target Audience The target audience for this activity a U.S.-based medical oncologists, oncology Advanced Practice Providers, oncology nurses and nurse navigators. Educational Objectives After completing this activity, the participant should be better able…
Carevive
May 30, 2019
CME

Applying a Shared Decision-Making Framework for Treatment Planning in DLBCL and FL

Release date: May 22, 2019 
Expiration date: May 21, 2020 Physicians – Maximum of 1.0 AMA PRA Category 1 Credits™ Registered Nurses – 1.0 contact hours (0.7 pharmacotherapy) Target Audience The target audience for this activity is U.S.-based hematologists/oncologists, advanced practice nurses, physician assistants, oncology nurses, nurse navigators, and cancer center administrators caring for patients with non-Hodgkin lymphoma. Educational Objectives After completing…
Carevive
May 22, 2019
CME

Evolving Evidence-Based Treatment Paradigms for Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)

Release date: April 15, 2019 
Expiration date: April 14, 2020 Estimated time to complete activity: 45 minutes In 2018, there will be an estimated 164,690 new cases of prostate cancer (PC) in the U.S. and approximately 29,430 patients will die of the disease, making it the third-leading cause of cancer death in men (American Cancer Society , 2018). The majority…
Carevive
April 15, 2019